Logo image of SKB.DE

KOENIG & BAUER AG (SKB.DE) Stock Fundamental Analysis

FRA:SKB - DE0007193500 - Common Stock

15.42 EUR
-0.72 (-4.46%)
Last: 8/29/2025, 7:00:00 PM
Fundamental Rating

2

SKB gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 106 industry peers in the Machinery industry. Both the profitability and financial health of SKB have multiple concerns. SKB is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year SKB has reported negative net income.
In the past year SKB had a positive cash flow from operations.
In multiple years SKB reported negative net income over the last 5 years.
SKB had a positive operating cash flow in 4 of the past 5 years.
SKB.DE Yearly Net Income VS EBIT VS OCF VS FCFSKB.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

SKB has a worse Return On Assets (-3.65%) than 78.30% of its industry peers.
With a Return On Equity value of -16.05%, SKB is not doing good in the industry: 81.13% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -3.65%
ROE -16.05%
ROIC N/A
ROA(3y)-1.34%
ROA(5y)-2.16%
ROE(3y)-6.04%
ROE(5y)-8.96%
ROIC(3y)N/A
ROIC(5y)N/A
SKB.DE Yearly ROA, ROE, ROICSKB.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 -30

1.3 Margins

Looking at the Gross Margin, with a value of 23.58%, SKB is doing worse than 77.36% of the companies in the same industry.
In the last couple of years the Gross Margin of SKB has declined.
SKB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.67%
GM growth 5Y-2.48%
SKB.DE Yearly Profit, Operating, Gross MarginsSKB.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1

2. Health

2.1 Basic Checks

SKB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SKB has about the same amount of shares outstanding.
SKB has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, SKB has a worse debt to assets ratio.
SKB.DE Yearly Shares OutstandingSKB.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
SKB.DE Yearly Total Debt VS Total AssetsSKB.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

Based on the Altman-Z score of 1.42, we must say that SKB is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of SKB (1.42) is worse than 65.09% of its industry peers.
SKB has a debt to FCF ratio of 31.18. This is a negative value and a sign of low solvency as SKB would need 31.18 years to pay back of all of its debts.
The Debt to FCF ratio of SKB (31.18) is worse than 69.81% of its industry peers.
A Debt/Equity ratio of 0.63 indicates that SKB is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.63, SKB is not doing good in the industry: 67.92% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 31.18
Altman-Z 1.42
ROIC/WACCN/A
WACC7.09%
SKB.DE Yearly LT Debt VS Equity VS FCFSKB.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 1.38 indicates that SKB should not have too much problems paying its short term obligations.
SKB has a Current ratio of 1.38. This is in the lower half of the industry: SKB underperforms 65.09% of its industry peers.
A Quick Ratio of 0.75 indicates that SKB may have some problems paying its short term obligations.
With a Quick ratio value of 0.75, SKB is not doing good in the industry: 76.42% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 0.75
SKB.DE Yearly Current Assets VS Current LiabilitesSKB.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

SKB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -42.70%.
SKB shows a small growth in Revenue. In the last year, the Revenue has grown by 2.41%.
Measured over the past years, SKB shows a small growth in Revenue. The Revenue has been growing by 0.45% on average per year.
EPS 1Y (TTM)-42.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.77%
Revenue 1Y (TTM)2.41%
Revenue growth 3Y4.53%
Revenue growth 5Y0.45%
Sales Q2Q%6.96%

3.2 Future

SKB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 60.40% yearly.
The Revenue is expected to grow by 4.41% on average over the next years.
EPS Next Y161.82%
EPS Next 2Y87.56%
EPS Next 3Y60.4%
EPS Next 5YN/A
Revenue Next Year2.62%
Revenue Next 2Y3.38%
Revenue Next 3Y3.45%
Revenue Next 5Y4.41%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SKB.DE Yearly Revenue VS EstimatesSKB.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
SKB.DE Yearly EPS VS EstimatesSKB.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4 -4 -6

5

4. Valuation

4.1 Price/Earnings Ratio

SKB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 6.96, the valuation of SKB can be described as very cheap.
SKB's Price/Forward Earnings ratio is rather cheap when compared to the industry. SKB is cheaper than 92.45% of the companies in the same industry.
SKB is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.72, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 6.96
SKB.DE Price Earnings VS Forward Price EarningsSKB.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

68.87% of the companies in the same industry are cheaper than SKB, based on the Enterprise Value to EBITDA ratio.
SKB's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 29.28
EV/EBITDA 16.49
SKB.DE Per share dataSKB.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

SKB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SKB's earnings are expected to grow with 60.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y87.56%
EPS Next 3Y60.4%

0

5. Dividend

5.1 Amount

SKB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

KOENIG & BAUER AG

FRA:SKB (8/29/2025, 7:00:00 PM)

15.42

-0.72 (-4.46%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)08-06 2025-08-06
Earnings (Next)11-05 2025-11-05
Inst Owners37.84%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap254.74M
Analysts82
Price Target18.34 (18.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.92%
PT rev (3m)6.75%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-17.94%
EPS NY rev (3m)-17.94%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.23%
Revenue NY rev (3m)-0.23%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.96
P/S 0.2
P/FCF 29.28
P/OCF 29.28
P/B 0.79
P/tB 0.79
EV/EBITDA 16.49
EPS(TTM)-3.11
EYN/A
EPS(NY)2.22
Fwd EY14.37%
FCF(TTM)0.53
FCFY3.42%
OCF(TTM)0.53
OCFY3.42%
SpS78.26
BVpS19.42
TBVpS19.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.65%
ROE -16.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.58%
FCFM 0.67%
ROA(3y)-1.34%
ROA(5y)-2.16%
ROE(3y)-6.04%
ROE(5y)-8.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.67%
GM growth 5Y-2.48%
F-Score4
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 31.18
Debt/EBITDA 7.07
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion 30.63%
Profit Quality N/A
Current Ratio 1.38
Quick Ratio 0.75
Altman-Z 1.42
F-Score4
WACC7.09%
ROIC/WACCN/A
Cap/Depr(3y)104.79%
Cap/Depr(5y)102.14%
Cap/Sales(3y)3.68%
Cap/Sales(5y)3.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-42.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.77%
EPS Next Y161.82%
EPS Next 2Y87.56%
EPS Next 3Y60.4%
EPS Next 5YN/A
Revenue 1Y (TTM)2.41%
Revenue growth 3Y4.53%
Revenue growth 5Y0.45%
Sales Q2Q%6.96%
Revenue Next Year2.62%
Revenue Next 2Y3.38%
Revenue Next 3Y3.45%
Revenue Next 5Y4.41%
EBIT growth 1Y-1043.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year442.46%
EBIT Next 3Y89.78%
EBIT Next 5Y47.44%
FCF growth 1Y123.45%
FCF growth 3Y-21.48%
FCF growth 5YN/A
OCF growth 1Y187%
OCF growth 3Y-8.24%
OCF growth 5YN/A